These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19451051

  • 21. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ, Cowan BJ, Hashimoto SA.
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [Abstract] [Full Text] [Related]

  • 22. Extracorporeal shock wave therapy for injection site panniculitis in multiple sclerosis patients.
    Stieger M, Schmid JP, Yawalkar N, Hunziker T.
    Dermatology; 2015 Mar; 230(1):82-6. PubMed ID: 25502016
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Localized lipoatrophy after glatiramer acetate injection in patients with remitting-relapsing multiple sclerosis.
    Drago F, Brusati C, Mancardi G, Murialdo A, Rebora A.
    Arch Dermatol; 1999 Oct; 135(10):1277-8. PubMed ID: 10522686
    [No Abstract] [Full Text] [Related]

  • 31. Ulnar neuropathy after glatiramer acetate subcutaneous injection: Ultrasound findings.
    Coraci D, Giovannini S, Loreti C, Padua L.
    J Clin Pharm Ther; 2019 Feb; 44(1):140-141. PubMed ID: 30315577
    [No Abstract] [Full Text] [Related]

  • 32. Methotrexate-induced papular eruption following treatment of psoriasis.
    Mebazaa A, Kenani N, Denguezli M, Ben Salem C, Ziadi S, Sriha B, Belajouza C, Nouira R.
    Ann Pharmacother; 2008 Jan; 42(1):138-41. PubMed ID: 18094347
    [Abstract] [Full Text] [Related]

  • 33. Multiple sclerosis therapeutics: unexpected outcomes clouding undisputed successes.
    Wiendl H, Hohlfeld R.
    Neurology; 2009 Mar 17; 72(11):1008-15. PubMed ID: 19289741
    [Abstract] [Full Text] [Related]

  • 34. Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetate.
    Nolden S, Casper C, Kuhn A, Petereit HF.
    Mult Scler; 2005 Apr 17; 11(2):245-8. PubMed ID: 15794402
    [Abstract] [Full Text] [Related]

  • 35. An MS patient loses trust when she finds out her doctor is paid by drug companies.
    Wolston M.
    Health Aff (Millwood); 2011 Dec 17; 30(12):2449-52. PubMed ID: 22147873
    [No Abstract] [Full Text] [Related]

  • 36. On cancer incidence in multiple sclerosis and effects of immunomodulatory treatments.
    Feigin PD.
    Breast Cancer Res Treat; 2005 Jul 17; 92(2):197. PubMed ID: 15986130
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Heparin-induced skin necrosis.
    Patel R, Lim Z, Dawe S, Salisbury J, Arya R.
    Br J Haematol; 2005 Jun 17; 129(6):712. PubMed ID: 15952995
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate.
    Frese A, Bethke F, Lüdemann P, Stögbauer F.
    J Neurol; 2000 Sep 17; 247(9):713. PubMed ID: 11081814
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.